跳至主要内容
临床试验/NCT02863315
NCT02863315Unknown不适用

The Effects of Anodal Transcutaneous Spinal Direct Current Stimulation on Chronic Neuropathic Pain After Spinal Cord Injury: Pilot Study

Seoul National University Hospital2 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2016年8月最近更新:
适应症

试验速览

阶段
不适用
入组人数
10
试验地点
2
主要终点
Numeric rating scale (NRS) for neuropathic pain

研究概览

简要总结

The purpose of this study is to evaluate the analgesic effect of transcutaneous spinal direct current stimulation (tsDCS) applied on spinal cord in patients with spinal cord injury who have chronic neuropathic pain.

详细描述

Twenty patients with spinal cord injury and bilateral neuropathic pain received single sessions of both sham and anodal tsDCS (2 mA) over tenth thoracic vertebra for 20 min (reference electrodes on the head vertex). Treatment order was randomly assigned. A evaluator rated the pain using the visual analogue scale for pain, Patient Global Assessment and Present Pain Intensity.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Single (Participant)

盲法说明

tsDCS

入排标准

年龄范围
20 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • cervical or upper thoracic complete motor spinal cord injury, at least 6 months after SCI, 20<=age<90
  • neuropathic pain (LANSS score >= 12), stable chronic pain for at least the three preceding months but not over 5 years
  • score higher than or equal to 4 cm (0 cm = 'no pain' and 10 cm = 'worst possible pain') on the visual ana- logue scale (VAS) for pain perception at the baseline/start of the treatment
  • refractoriness to drugs for pain relief - such as tricyclic antidepressants, antiepileptic drugs, and/or narcot- ics (pain resistant to at least two of these drugs supplied in ade- quate dosages for 6 months)
  • informed consent

排除标准

  • patients with any clinically significant or unstable medical or progressive neurologic disorder
  • contraindication for electrial stimulation such as pacemaker implant
  • Women of childbearing age or pregnancy
  • significant cognitive deficit
  • Syringomyelia
  • neuropsychiatric comorbidity
  • depressive disorder (as indicated by a score of 10 greater on the Beck Depression Inventory)
  • history of substance abuse
  • skin defect under the electrodes
  • progressive neurological disease or other secondary conditions that could impact neuropathic pain

结局指标

主要结局

Numeric rating scale (NRS) for neuropathic pain

时间窗: Baseline NRS (average NRS over the preceding 24h), Change from Baseline NRS at 0, 60 and 120 minutes after the start of the stimulation

On a scale of 0 to 10, with 0 being no pain at all and 10 being the worst pain imaginable

次要结局

  • Patient Global Assessment (PGA)(Baseline PGA (average PGA over the preceding 24h), Change from Baseline PGA at 0, 60 and 120 minutes after the start of the stimulation)
  • Present Pain Intensity (PPI)(Baseline PPI (average PPI over the preceding 24h), Change from Baseline PPI at 0, 60 and 120 minutes after the start of the stimulation)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Hyung-ik Shin

Professor

Seoul National University Hospital

研究点 (2)

Loading locations...

相似试验